跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,899 条关于
“Talphera, Inc.”
全部
40,899
临床试验
11,203
药物
1,599
机构
6,170
资讯
21,927
去年
Talphera's Niyad Receives FDA Agreement for Enrollment Acceleration in NEPHRO CRRT Trial
去年
CorMedix Makes $5 Million Strategic Investment in Talphera's Phase 3 Anticoagulant Program
上个月
Talphera's nafamostat gains KDIGO endorsement as NEPHRO CRRT trial nears completion
去年
XOMA Royalty Expands Portfolio to Over 120 Assets, Reports Financial Results for 2024
去年
Talphera Accelerates Nafamostat Trial Enrollment with Strategic Site Optimization
6个月前
Talphera Reaches 50% Enrollment in Nafamostat CRRT Trial, Targets 2026 FDA Filing
去年
Talphera Shares Surge 20% on NEPHRO CRRT Trial Enrollment Milestone
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
第 1 页,共 2193 页
上一页
下一页